Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Macular telangiectasia type 2

MONDO:1010183

A macular telangiectasia that causes slow deterioration of central vision, typically appearing in people between the ages of 50 and 60. It is characterized by the dilation and leakage of blood vessels in the macula, the part of the retina responsible for sharp, detailed vision, and is also linked to neurodegeneration in retinal cells.

Also known as: MacTel type 2, MacTel2

11 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Eye disorder (97) Human disease (14) Disorder of orbital region (3) Disorder of visual system (1) Macular telangiectasia (1) Disease by body system or component (0)
Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1
Sort by
  • VR headsets tested as a possible treatment for blindness

    Disease control Terminated

    This study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…

    Phase: NA • Sponsor: Stanford University • Aim: Disease control

    Last updated Jun 27, 2026 08:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space